Pfizer (PFE) Preferred Shares (2009 - 2020)

Pfizer has disclosed Preferred Shares across 12 years of filings, most recently posting $17.0 million for Q1 2020.

• In Q1 2020, Preferred Shares fell 10.53% year-over-year to $17.0 million; the TTM figure through Mar 2020 stood at $17.0 million (down 10.53% YoY), while the FY2019 annual figure was $17.0 million, down 10.53% from the prior year.
• Preferred Shares held at $17.0 million in Q1 2020, from $17.0 million in the prior quarter.
• Over the last five years, Preferred Shares for PFE reached as high as $26.0 million in Q2 2016 and fell as low as $17.0 million in Q4 2019.
• The 5-year median for Preferred Shares is $21.0 million (2017), against an average of $21.1 million.
• Annual changes were most pronounced in 2016 — Preferred Shares fell 7.14% — and 2018, when it fell 13.04%.
• A 5-year view of Preferred Shares shows it stood at $24.0 million in 2016, then fell by 12.5% to $21.0 million in 2017, then declined by 9.52% to $19.0 million in 2018, then decreased by 10.53% to $17.0 million in 2019, then changed by 0.0% to $17.0 million in 2020.
• According to Business Quant data, Preferred Shares over the past three periods registered $17.0 million, $17.0 million, and $18.0 million for Q1 2020, Q4 2019, and Q3 2019 respectively.